comparemela.com

Latest Breaking News On - Rosalind advisors inc - Page 1 : comparemela.com

Rezolute, Inc. (NASDAQ:RZLT) Sees Large Increase in Short Interest

Rezolute, Inc. (NASDAQ:RZLT – Get Free Report) was the recipient of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 814,600 shares, a growth of 162.0% from the May 15th total of 310,900 shares. Based on an average daily trading volume, of 571,100 shares, […]

United-states
Daron-evans
Craig-hallum
Rosalind-advisors-inc
Vanguard-group-inc
Virtu-financial
Acadian-asset-management
Affinity-asset-advisors
Securities-exchange-commission
Rezolute-inc
Nasdaq
Maxim-group

Veru (NASDAQ:VERU) Share Price Passes Above 200-Day Moving Average of $0.85

Veru Inc. (NASDAQ:VERU – Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.85 and traded as high as $1.03. Veru shares last traded at $0.98, with a volume of 928,103 shares. Wall Street Analysts Forecast Growth A number of analysts […]

Mitchell-shuster-steiner
Raymond-james
Cetera-advisors
Ikarian-capital
Veru-inc
Alpine-global-management
Securities-exchange-commission
Nasdaq
Rosalind-advisors-inc
Veru-company-profile
Get-free-report
Shuster-steiner

Beyond Air (NASDAQ:XAIR) Stock Price Down 8.6%

Beyond Air, Inc. (NASDAQ:XAIR – Get Free Report) shares fell 8.6% during trading on Monday . The stock traded as low as $1.16 and last traded at $1.17. 481,752 shares changed hands during trading, an increase of 45% from the average session volume of 331,472 shares. The stock had previously closed at $1.28. Analyst Ratings […]

United-states
Gendell-jeffrey
Keel-point
Nasdaq
Vanguard-group-inc
Wealth-effects
Rosalind-advisors-inc
Beyond-air
Get-free-report
Truist-financial
Beyond-air-daily

Unicycive Therapeutics' (UNCY) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reissued their buy rating on shares of Unicycive Therapeutics (NASDAQ:UNCY – Free Report) in a report issued on Wednesday, Benzinga reports. The brokerage currently has a $4.50 price objective on the stock. Several other brokerages have also recently commented on UNCY. Noble Financial started coverage on Unicycive Therapeutics in a research report on […]

United-states
Piper-sandler
Unicycive-therapeutics-company-profile
Vivo-capital
Virtu-financial
Rosalind-advisors-inc
Unicycive-therapeutics-inc
Unicycive-therapeutics
Free-report
Get-free-report
Unicycive-therapeutics-daily

PolyPid (NASDAQ:PYPD) Trading 0.2% Higher

PolyPid Ltd. (NASDAQ:PYPD – Get Free Report)’s stock price rose 0.2% during mid-day trading on Thursday . The company traded as high as $4.67 and last traded at $4.50. Approximately 5,148 shares traded hands during trading, a decline of 9% from the average daily volume of 5,662 shares. The stock had previously closed at $4.49. […]

Exchange-commission
Nasdaq
Polypid-ltd
Rosalind-advisors-inc
Polypid-company-profile
Get-free-report
Free-report
Rosalind-advisors
Cupid-ltd
Polypid-daily

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.